Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management.
Erickson
J R
JR
Atairgin Technologies, Irvine, CA 92612 USA.
Hasegawa
Y
Y
Fang
X
X
Eder
A
A
Mao
M
M
Furui
T
T
Aoki
J
J
Morris
A
A
Mills
G B
GB
D023102:Anoikis; D002471:Cell Transformation, Neoplastic; D005260:Female; D006801:Humans; D008246:Lysophospholipids / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D010051:Ovarian Neoplasms / Q000209:etiology* / Q000628:therapy*; D010053:Ovary / Q000187:drug effects; D015398:Signal Transduction
D008246:Lysophospholipids